Apolipoprotein E4 iPSC-derived variants are thought to be the greatest genetic risk factor for sporadic AD, and the investigators used CRISPR/Cas9 to create homozygous iPSC lines containing a pure Apo-E4 allele from unaffected parental Apo-E3 cells. This evidence concerns the gene APOE and Alzheimer disease.